Clinical Trial Update: Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Efbemalenograstim alfa injection in patients with ovarian or cervical cancer receiving chemotherapy. The study is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Ovarian Cancer

Drugs mentioned

• Efbemalenograstim Alfa Injection (efbemalenograstim alfa)

Snippet

Sponsor: Shandong University | Conditions: Ovarian Cancer, Cervical Cancer | Phase 2 | Status: RECRUITING